Immunogenicity of a recombinant yeast-derived hepatitis b vaccine

M. Pamukçu; G. Mutlu; G. Yakupoğlu; G. Süleymanlar; 0. Yeğin

Research Article

Immunogenicity of a recombinant yeast-derived hepatitis b vaccine

Year 1991, Volume: 4 Issue: 1, 31 - 35, 01.01.1991

M. Pamukçu G. Mutlu G. Yakupoğlu G. Süleymanlar 0. Yeğin

Abstract

We examined the immunogcnicity and rcactigeni- city of a recombinant DNA yeast-derived hepatitis B vaccine in healthy adults. Thirty medical professionals who bad been working at the Akdcniz University Hospital were vaccinated with hepatitis B vaccine according to a 0,1, and 6 month vaccination schedule. One month after the third dose, seroconversion rate was 100% and all subjects had antibodies to hepatitis B surface antigen tilers in excess of 10IU / L. No serious adverse reactions attributable to the vaccine, were observed.

Keywords

Hepatitis B, prevention and control

Year 1991, Volume: 4 Issue: 1, 31 - 35, 01.01.1991

M. Pamukçu G. Mutlu G. Yakupoğlu G. Süleymanlar 0. Yeğin

Abstract

There are 0 citations in total.

Details

Subjects	Clinical Sciences
Journal Section	Articles
Authors	M. Pamukçu This is me G. Mutlu This is me G. Yakupoğlu This is me G. Süleymanlar This is me 0. Yeğin This is me
Publication Date	January 1, 1991
Published in Issue	Year 1991 Volume: 4 Issue: 1

Cite

APA	Pamukçu, M., Mutlu, G., Yakupoğlu, G., Süleymanlar, G., et al. (1991). Immunogenicity of a recombinant yeast-derived hepatitis b vaccine. Marmara Medical Journal, 4(1), 31-35.
AMA	Pamukçu M, Mutlu G, Yakupoğlu G, Süleymanlar G, Yeğin 0. Immunogenicity of a recombinant yeast-derived hepatitis b vaccine. Marmara Med J. January 1991;4(1):31-35.
Chicago	Pamukçu, M., G. Mutlu, G. Yakupoğlu, G. Süleymanlar, and 0. Yeğin. “Immunogenicity of a Recombinant Yeast-Derived Hepatitis B Vaccine”. Marmara Medical Journal 4, no. 1 (January 1991): 31-35.
EndNote	Pamukçu M, Mutlu G, Yakupoğlu G, Süleymanlar G, Yeğin 0. (January 1, 1991) Immunogenicity of a recombinant yeast-derived hepatitis b vaccine. Marmara Medical Journal 4 1 31–35.
IEEE	M. Pamukçu, G. Mutlu, G. Yakupoğlu, G. Süleymanlar, and 0. Yeğin, “Immunogenicity of a recombinant yeast-derived hepatitis b vaccine”, Marmara Med J, vol. 4, no. 1, pp. 31–35, 1991.
ISNAD	Pamukçu, M. et al. “Immunogenicity of a Recombinant Yeast-Derived Hepatitis B Vaccine”. Marmara Medical Journal 4/1 (January 1991), 31-35.
JAMA	Pamukçu M, Mutlu G, Yakupoğlu G, Süleymanlar G, Yeğin 0. Immunogenicity of a recombinant yeast-derived hepatitis b vaccine. Marmara Med J. 1991;4:31–35.
MLA	Pamukçu, M. et al. “Immunogenicity of a Recombinant Yeast-Derived Hepatitis B Vaccine”. Marmara Medical Journal, vol. 4, no. 1, 1991, pp. 31-35.
Vancouver	Pamukçu M, Mutlu G, Yakupoğlu G, Süleymanlar G, Yeğin 0. Immunogenicity of a recombinant yeast-derived hepatitis b vaccine. Marmara Med J. 1991;4(1):31-5.